Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9203 |
High Similarity |
NPD1549 |
Phase 2 |
0.913 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.913 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9124 |
High Similarity |
NPD1510 |
Phase 2 |
0.9085 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9085 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8971 |
High Similarity |
NPD1240 |
Approved |
0.8841 |
High Similarity |
NPD1607 |
Approved |
0.8786 |
High Similarity |
NPD2796 |
Approved |
0.8716 |
High Similarity |
NPD7411 |
Suspended |
0.8658 |
High Similarity |
NPD6801 |
Discontinued |
0.8649 |
High Similarity |
NPD4380 |
Phase 2 |
0.86 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD7075 |
Discontinued |
0.8543 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8477 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8472 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8446 |
Intermediate Similarity |
NPD920 |
Approved |
0.8411 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8403 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8367 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8345 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8299 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8264 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8228 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8158 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8153 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8079 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8077 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8075 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8028 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7945 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7929 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7911 |
Intermediate Similarity |
NPD919 |
Approved |
0.7902 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7899 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7888 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7868 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7866 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7862 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7838 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7737 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7722 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7711 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD943 |
Approved |
0.7655 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD2309 |
Approved |
0.763 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7566 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.756 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD3268 |
Approved |
0.753 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2654 |
Approved |
0.75 |
Intermediate Similarity |
NPD2798 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7429 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD411 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7315 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD3267 |
Approved |
0.731 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7237 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5890 |
Approved |
0.72 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7172 |
Intermediate Similarity |
NPD4749 |
Approved |
0.717 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2296 |
Approved |
0.707 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7014 |
Intermediate Similarity |
NPD17 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD74 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD5408 |
Approved |
0.6968 |
Remote Similarity |
NPD5406 |
Approved |
0.6968 |
Remote Similarity |
NPD5404 |
Approved |
0.6968 |
Remote Similarity |
NPD5405 |
Approved |
0.6962 |
Remote Similarity |
NPD3887 |
Approved |
0.6959 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD7577 |
Discontinued |
0.6951 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6947 |
Remote Similarity |
NPD4377 |
Discontinued |
0.6937 |
Remote Similarity |
NPD4662 |
Approved |
0.6937 |
Remote Similarity |
NPD4661 |
Approved |
0.6934 |
Remote Similarity |
NPD9263 |
Approved |
0.6934 |
Remote Similarity |
NPD9267 |
Approved |
0.6934 |
Remote Similarity |
NPD9264 |
Approved |
0.6934 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6923
|
Remote Similarity |
NPD2353 |
Approved |